Furthermore, high expression of S100A8 is associated with chemoresistance in AML [7] whilst calprotectin (S100A8/S100A9 heterodimer) causes glucocorticoid resistance in infant ALL [8]. Here, S100A9 is linked to acute myeloid leukemia.